Listed by the USPTO as ALLEY, GENEVIEVE S
Tech Center 1600 • Art Units: 1611 1614 1617 1619
This examiner grants 60% of resolved cases
ALLEY, GENEVIEVE S is assigned to Tech Center 1600 and Art Unit 1611. The profile covers 739 resolved cases, with a 60.5% allowance rate and a 48.3% interview lift. Median time to allowance is 1067 days. Interviews show a substantial association with allowance outcomes, making early discussion planning relevant to prosecution strategy.
Top companies include Merck Patent GmbH, Kaneka Corporation, and Syngenta AG. The leading firms are Abel Schillinger, LLP, Buchanan Ingersoll & Rooney PC, and DANN, DORFMAN, HERRELL & SKILLMAN. This recurring participant set provides context for biotechnology and chemical matters in the docket.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18835879 | METAL EFFECT PIGMENTS WITH SURFACE-TREATMENTS, PREPARING METHOD AND USE OF SAME | Non-Final OA | MERCK PATENT GmbH |
| 18589817 | SKIN PENETRATION IMPROVER | Final Rejection | KANEKA CORPORATION |
| 18750592 | NANOPARTICLE (NP)-ENHANCED EXPRESSION OF AQUAPORIN-4 CHANNELS AND WATER TRANSPORT IN HUMAN ASTROCYTES | Final Rejection | The Government of the United States of America, as represented by the Secretary of the Navy |
| 18716697 | Herbicidal Compositions | Final Rejection | Syngenta Crop Protection AG |
| 18727863 | POTASSIUM-SODIUM TARTRATE AS GRANULATING AID | Non-Final OA | BASF SE |
| 18892456 | Indane Derivatives for Malodor Counteraction | Non-Final OA | Firmenich SA |
| 18975545 | Use of short chain fatty acids for the treatment and prevention of diseases and disorders | Non-Final OA | Temple University-Of The Commonwealth System of Higher Education |
| 18692408 | RAPIDLY DISINTEGRATING ORAL THIN-FILMS/FOAMS HAVING A HIGH ACTIVE-INGREDIENT CONTENT BASED ON A MIXTURE OF POLYVINYL ALCOHOLS HAVING VARIOUS MOLECULAR WEIGHTS | Final Rejection | LTS Lohmann Therapie-Systeme AG |
| 18551835 | A SYNERGISTIC PLANT GROWTH STIMULANT COMPOSITION COMPRISING POTASSIUM MONO/DIFORMATE AND METAL ION COMPOUNDS TO ENHANCED METABOLIC ACTIVITIES IN PLANTS | Final Rejection | FERTIS INDIA PVT LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.5% of resolved applications examined by Genevieve S Alley were allowed (739 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +48.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Genevieve S Alley took 1,067 days on average from filing to allowance.
Genevieve S Alley examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
